DRVAX: Dreman Contrarian Value Equity A

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

DRVAX Dreman Contrarian Value Equity A


Profile

DRVAX - Profile

Vitals

  • YTD Return N/A
  • 3 Yr Annualized Return N/A
  • 5 Yr Annualized Return N/A
  • Net Assets $1.43 M
  • Holdings in Top 10 21.8%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING RELATED FEES

  • Expense Ratio 58.68%

SALES FEES

  • Front Load 5.75%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover N/A

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

Closed to new investors as of Dec 28, 2012
  • Standard (Taxable) $2,500
  • IRA $2,500

Fund Classification

  • Primary Caregory N/A
  • Fund Type Open End Mutual Fund
  • Investment Style Large Value

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 1.10%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    Dreman Contrarian Value Equity Fund
  • Fund Family Name
    N/A
  • Inception Date
    Apr 25, 2011
  • Shares Outstanding
    N/A
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    United States

Fund Description

The fund will invest at least 80% of its assets (including borrowings for investment purposes) in common stocks that at the time of purchase are similar in market capitalization to those listed on the Russell 3000 Index. It may invest up to 20% of its assets in foreign securities, including American Depository Receipts ("ADRs") or Global Depository Receipts ("GDRs") that are traded on U.S. markets. The fund intends to remain substantially invested in equity securities, but may invest up to 20% of its assets in investment-grade fixed income securities of any maturity.


Get Updates About DRVAX

Sign up for Advisor Access to receive email updates about DRVAX competitors, news, CE accredited webcasts and more.


Categories

DRVAX - Mutual Fund Categories


Performance

DRVAX - Performance

Return Ranking - Trailing

Period DRVAX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -50.0% 268.1% N/A
1 Yr 12.6% -64.8% 268.1% N/A
3 Yr N/A* -100.0% 115.6% N/A
5 Yr N/A* -100.0% 58.6% N/A
10 Yr N/A* -12.1% 26.2% N/A

* Annualized

Return Ranking - Calendar

Period DRVAX Return Category Return Low Category Return High Rank in Category (%)
2019 N/A -100.0% 73.0% N/A
2018 N/A -76.0% 212.6% N/A
2017 N/A -65.0% 900.0% N/A
2016 N/A -87.3% 336.8% N/A
2015 N/A -60.1% 304.1% N/A

Total Return Ranking - Trailing

Period DRVAX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -50.0% 268.1% N/A
1 Yr 6.2% -64.8% 268.1% N/A
3 Yr N/A* -100.0% 115.6% N/A
5 Yr N/A* -100.0% 58.6% N/A
10 Yr N/A* -12.1% 26.3% N/A

* Annualized

Total Return Ranking - Calendar

Period DRVAX Return Category Return Low Category Return High Rank in Category (%)
2019 N/A -100.0% 76.6% N/A
2018 N/A -30.7% 212.6% N/A
2017 N/A -65.0% 900.0% N/A
2016 N/A -87.3% 341.1% N/A
2015 N/A -60.1% 304.1% N/A

NAV & Total Return History


Holdings

DRVAX - Holdings

Concentration Analysis

DRVAX Category Low Category High DRVAX % Rank
Net Assets 1.43 M 10 804 B N/A
Number of Holdings 51 1 17333 N/A
Net Assets in Top 10 313 K -7.11 B 145 B N/A
Weighting of Top 10 21.75% 0.0% 20474.3% N/A

Top 10 Holdings

  1. Citigroup Inc 2.27%
  2. Bank of America Corporation 2.26%
  3. Goldman Sachs Group Inc 2.20%
  4. Thermo Fisher Scientific Inc 2.16%
  5. Hartford Financial Services Group Inc 2.16%
  6. Yamana Gold Inc 2.16%
  7. Bank of New York Mellon Corp 2.15%
  8. Symantec Corp 2.13%
  9. Alliant Techsystems Inc 2.13%
  10. Carnival Corporation 2.12%

Asset Allocation

Weighting Return Low Return High DRVAX % Rank
Stocks
97.21% -142.98% 259.25% N/A
Cash
2.80% -2458.20% 7388.76% N/A
Preferred Stocks
0.00% -21.20% 80.89% N/A
Other
0.00% -7288.76% 493.15% N/A
Convertible Bonds
0.00% -0.37% 144.58% N/A
Bonds
0.00% -955.59% 2458.15% N/A

Stock Sector Breakdown

Weighting Return Low Return High DRVAX % Rank
Financial Services
30.44% -7.59% 99.69% N/A
Industrials
15.43% -19.53% 93.31% N/A
Energy
14.64% -6.25% 144.83% N/A
Technology
12.78% -26.81% 99.57% N/A
Healthcare
10.13% -15.38% 100.00% N/A
Basic Materials
6.17% -5.18% 96.19% N/A
Consumer Cyclical
5.54% -20.80% 87.44% N/A
Consumer Defense
2.08% -7.54% 98.24% N/A
Utilities
0.00% -3.80% 94.95% N/A
Real Estate
0.00% -8.52% 100.26% N/A
Communication Services
0.00% -9.27% 90.02% N/A

Stock Geographic Breakdown

Weighting Return Low Return High DRVAX % Rank
US
87.04% -142.98% 149.27% N/A
Non US
10.17% -38.73% 159.65% N/A

Expenses

DRVAX - Expenses

Operational Fees

DRVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 58.68% -2.86% 950.64% N/A
Management Fee 0.70% 0.00% 2.87% N/A
12b-1 Fee 0.25% 0.00% 1.00% N/A
Administrative Fee 465000.00% 0.00% 52000.00% N/A

Sales Fees

DRVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 0.00% 25.00% N/A
Deferred Load N/A 0.25% 5.50% N/A

Trading Fees

DRVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

DRVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 5067.00% N/A

Distributions

DRVAX - Distributions

Dividend Yield Analysis

DRVAX Category Low Category High DRVAX % Rank
Dividend Yield 0.00% 0.00% 84.51% N/A

Dividend Distribution Analysis

DRVAX Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Monthly Annually

Net Income Ratio Analysis

DRVAX Category Low Category High DRVAX % Rank
Net Income Ratio 1.10% -46.00% 10.88% N/A

Capital Gain Distribution Analysis

DRVAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

DRVAX - Fund Manager Analysis

Tenure Analysis

Category Low Category High Category Average Category Mode
0.01 33.52 5.37 3.25